SCHEMBL2928020

SCHEMBL2928020

CCCCC(=O)Nc1cc(NC(=O)OC(C)(C)C)ccc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 6/20 0.50
HDAC1 Q13547 4/20 0.50
HDAC2 Q92769 3/20 0.50
HDAC10 Q969S8 2/20 0.50
NCOR2 Q9Y618 2/20 0.50
HDAC6 Q9UBN7 1/20 0.50
ALDH1A1 P00352 4/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
HDAC8 Q9BY41 2/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 2/20 0.44
KDM4E B2RXH2 1/20 0.43
ALOX12 P18054 1/20 0.43
TP53 P04637 1/20 0.43
RAB9A P51151 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14068644 0.83 CA1 (0.56) HDAC3HDAC1HDAC2NCOR2ALDH1A1
SCHEMBL2925559 0.80 POLB (0.43) HDAC3HDAC1HDAC2HDAC10NCOR2
SCHEMBL6813967 0.79 CA1 (0.56) HDAC3HDAC1HDAC2NCOR2ALDH1A1
SCHEMBL4015472 0.76 KDM4E (0.50) HDAC3HDAC1HDAC2HDAC10NCOR2
SCHEMBL13624134 0.76 CA12 (0.50) HDAC3HDAC1HDAC2HDAC6ALDH1A1
SCHEMBL7071047 0.76 AAK1 (0.48) HDAC3HDAC1HDAC2HDAC10NCOR2
SCHEMBL30896828 0.76 CA12 (0.41) HDAC3HDAC1HDAC2HDAC10NCOR2
SCHEMBL396942 0.75 CA12 (0.47) ALDH1A1CA1RAB9ACA12CA9
SCHEMBL14068236 0.75 TP53 (0.62) HDAC3HDAC1HDAC2HDAC10NCOR2
SCHEMBL13076791 0.74 CA12 (0.42) ALDH1A1CA1HPGDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1675824-B1 SOMATOSTATIN RECEPTOR 1 AND/OR 4 SELECTIVE AGONISTS AND ANTAGONISTS WURSTER SIEGFRIED (FI) 2010-09-29 EP disclosed
US-7741362-B2 Somatostatin receptor 1 and/or 4 selective agonists and antagonists SIEGFRIED WURSTER (FI) 2010-06-22 US disclosed
US-20100004339-A1 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists OY JUVANTIA PHARMA LTD. (FI) 2010-01-07 US disclosed
US-20070129422-A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists OY JUVANTIA PHARMA LTD (FI) 2007-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070129422-A1 Somatostatin receptor 1 and/or 4 selective agonists and antagonists SSTR4, SSTR1, SSTR3 HDAC3 1633/4885HDAC1 1939/4885HDAC2 2347/4885
US-20100004339-A1 Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists SSTR4, SSTR1, SSTR3 HDAC3 1633/4885HDAC1 1939/4885HDAC2 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.